Pharmacology Flashcards
Type A Drug RXN
Related to pharmacodynamics of a drug
- dose dependent and predictable
- Known SE of meds
Type B Drug RXN
Unrelated to pharmacodynamics of drug
- Unpredictable and mostly immunological
- E.g. drug rash
Clearance units
L/min
1st order kinetics
same AMOUNT of drug eliminated per unit of time
Dependent on cencentration
Zero order kinetics
same PROPORTION of drug eliminated per unit of time
Independent of concentration
Dopamine MOA
D1 - Low doses - vasodilation
Beta 1 - Intermediate doses - Increase chronotropy (HR) and inotropy (SV)
alpha 1 - High doses - Vasoconstriction
Adrenaline/Noradrenaline MOA
Mostly Alpha 1 - vasoconstriction
Some Beta 1 and 2
Dobutamine MOA
Mostly Beta1 and Beta2
Neprolysin inhibitor MOA
• Inhibition of neprilysin (a neutral endopeptidase) raises levels of several endogenous vasoactive peptides, including natriuretic peptides, bradykinin, and adrenomedullin, and may thus have beneficial effects in patients with HF.
MOA Tranexamic acid
Inhibits breakdown of clots by blocking binding of plasminogen and plasmin to fibrin.
Elimination definition
Elimination refers to the irreversible removal of drug from the body by all routes of elimination
Clearance definition
Clearance may be defined as the volume of fluid cleared of drug from the body per unit of time
PTU MOA
Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine.
Carbimazole MOA
Carbimazole is a pro-drug as after absorption it is converted to the active form,methimazole. Methimazole prevents thyroid peroxidase enzyme from coupling and iodinating the tyrosine residues on thyroglobulin, hence reducing the production of the thyroid hormones T3 and T4
Potassium iodine MOA in Thyroid
iodine acutely inhibits hormonal secretion within hours [1], but the responsible mechanisms are uncertain.
MMF MOA
selectively suppresses lymphocyte proliferation and antibody formation by inhibiting inosine monophosphate dehydrogenase.
Which drug of abuse causes increased risk of seizures
Cocaine
Which OTC supp can cause hepatotoxicity
Valerian
achievement of steady state concentration is significantly delayed because this drug induces its own metabolism
CArbamazepine
Phase 0 Trial
To determine if drug engages its expected target
Phase 1 Trial
Initial safety check:
- Determine safe dosage range
- Identify SE and study toxicity profile
Phase 2 Trial
Explore efficacy while maintaining safety usually against placebo
Phase 3 Trial
Multiple dose trials and ascending dose trials
Phase 4 Trial
Trials after FDA approval